Wellington Management Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-699,814
| Closed | -$8.16M | – | 1993 |
|
|
2024
Q4 | $8.16M | Buy |
699,814
+55,051
| +9% | +$642K | ﹤0.01% | 1247 |
|
|
2024
Q3 | $13.2M | Sell |
644,763
-137,011
| -18% | -$2.82M | ﹤0.01% | 1088 |
|
|
2024
Q2 | $17.5M | Sell |
781,774
-3,380,355
| -81% | -$75.7M | ﹤0.01% | 997 |
|
|
2024
Q1 | $115M | Buy |
4,162,129
+1,705,212
| +69% | +$46.9M | 0.02% | 521 |
|
|
2023
Q4 | $74.9M | Sell |
2,456,917
-195,077
| -7% | -$5.95M | 0.01% | 622 |
|
|
2023
Q3 | $83.9M | Buy |
2,651,994
+36,630
| +1% | +$1.16M | 0.02% | 576 |
|
|
2023
Q2 | $107M | Sell |
2,615,364
-350,776
| -12% | -$14.3M | 0.02% | 532 |
|
|
2023
Q1 | $111M | Buy |
2,966,140
+971,952
| +49% | +$36.2M | 0.02% | 516 |
|
|
2022
Q4 | $69.6M | Buy |
1,994,188
+1,418,896
| +247% | +$49.5M | 0.01% | 606 |
|
|
2022
Q3 | $32.2M | Sell |
575,292
-84,607
| -13% | -$4.73M | 0.01% | 776 |
|
|
2022
Q2 | $34.2M | Sell |
659,899
-118,613
| -15% | -$6.14M | 0.01% | 789 |
|
|
2022
Q1 | $56.6M | Buy |
778,512
+167,764
| +27% | +$12.2M | 0.01% | 722 |
|
|
2021
Q4 | $72.2M | Buy |
610,748
+26,940
| +5% | +$3.19M | 0.01% | 720 |
|
|
2021
Q3 | $78.3M | Buy |
583,808
+268,167
| +85% | +$36M | 0.01% | 691 |
|
|
2021
Q2 | $51.1M | Buy |
+315,641
| New | +$51.1M | 0.01% | 819 |
|